Study examines access to 121 drugs approved since 2015 by EU regulator

Medicines generally blocked on basis of price as Ipha says delay ‘unacceptably long’

Spinraza is the latest in a series of controversial drugs that have put Ireland’s unique approval system in the spotlight

Cantillon: Patients have one shot at treatment but what if it is deemed too expensive?

Row between industry and body that advises the HSE over access to market for new medicines

Labour TD criticises selective provision of drug to women caught up in CervicalCheck controversy

‘It’s also important for researchers to hear what patients want from new drugs’

‘You have to ask why other countries have been happy with the clinical evidence but not here’ - mother of girl (10)

HSE representatives defend process for deciding which drugs to reimburse

Healthcare companies gave €30 million to hospitals, medical staff in 2016, says Minister

Kuvan is the only drug treatment for rare metabolic ‘heel prick test’ disorder

HSE decides against approving Translarna for reimbursement under drugs schemes

Department says it is considering three medicines for approval

Manufacturer accuses HSE of deviating from approvals processes by blocking Perjeta

More patients are switching to Long-Term Illness scheme to avoid paying charge

Over 20 emphysema sufferers to see use of ‘life changing’ Respreeza finish in two weeks

Over 20 sufferers are given Respreeza reprieve while talks continue on approving the treatment

Nellie Lannen (22 months) has condition causing muscle wastage, impaired breathing

US pharma Vertex in talks with HSE to reduce high price of cystic fibrosis drug

Negotiations with manufacturer ongoing as Harris accuses Vertex of trying to ‘extort’ taxpayers